ANI Pharmaceuticals logo
ANI Pharmaceuticals ANIP
$ 55.64 0.97%

Quarterly report 2024-Q3
added 11-08-2024

report update icon

ANI Pharmaceuticals Financial Ratios 2011-2024 | ANIP

Annual Financial Ratios ANI Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

64.2 -14.6 -12.0 -15.1 119.0 40.9 -724.0 169.4 23.7 21.3 355.8 -1.1 -1.2

P/S

2.5 2.2 2.4 1.6 3.5 3.1 4.4 5.2 4.8 10.9 3.6 13.7 147.0

EPS

0.9 -3.0 -3.4 -1.9 0.5 1.3 -0.1 0.3 1.3 2.6 -0.9 -1.3 -3.1

EV (Enterprise Value)

1.43 B 1.07 B 822 M 599 M 907 M 824 M 985 M 792 M 334 M 567 M 99.5 M 42.1 M 31.3 M

EBITDA per Share

5.93 1.33 0.59 2.39 5.15 5.92 4.95 4.29 3.48 2.18 0.396 -6.32 -18.6

EV/EBITDA

109.5 17.9 13.9 11.2 16.6 15.5 8.1 23.2 47.8 -0.2 -0.5

PEG

0.98 -23.38 0.56 9.0 -1.95 0.03 5.74 -2.28 -0.49 0.06 4.05 -0.02 -0.05

P/B

2.6 2.1 1.4 1.7 3.4 3.2 4.5 3.9 2.3 4.4 2.6 1.1 1.7

P/CF

10.1 -22.4 153.3 22.4 40.1 11.3 -11.4 -5.5 -23.6 -44.6 -18.9 -1.2 -1.3

ROE %

4.34 -15.27 -12.76 -11.52 2.86 7.85 -0.62 2.32 9.60 20.57 0.73 -98.38 -136.48

ROA %

2.08 -6.30 -5.52 -4.89 1.33 3.60 -0.26 1.22 5.39 10.90 0.68 -71.49 -82.73

ROCE %

10.85 -11.25 -11.92 -8.18 4.16 13.34 7.84 9.20 11.96 7.99 2.19 -82.24 -92.34

Current Ratio

2.0 1.8 1.9 1.7 3.0 0.9 3.4 3.2 16.4 15.4 7.8 3.3 8.0

DSO

122.8 169.6 189.4 147.0 127.5 117.4 121.3 130.2 104.9 112.8 151.8 - -

DIO

217.7 246.0 258.5 228.2 278.4 202.4 174.2 195.9 385.0 239.2 128.7 - -

DPO

66.3 68.7 62.1 54.2 84.4 44.4 16.8 25.4 59.4 84.4 52.3 - 22999.9

Operating Cycle

340.5 415.5 447.9 375.2 405.8 319.9 295.6 326.2 489.9 352.0 280.6 - -

Cash Conversion Cycle

274.2 346.8 385.8 321.0 321.4 275.5 278.8 300.8 430.5 267.5 228.3 - -22999.9

All numbers in USD currency

Quarterly Financial Ratios ANI Pharmaceuticals

2024-Q3 2024-Q2 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-1.27 -0.14 0.46 0.3 0.06 - -0.55 -0.94 -1.27 - -0.37 -1.17 0.01 -0.3 0.04 -1.03 -0.59 -0.41 0.32 0.55 0.04 0.46 0.43 0.24 0.19 -0.83 0.41 0.23 0.1 -0.09 0.22 0.1 0.12 0.25 0.4 0.31 0.38 1.85 0.59 -0.21 0.33 - 0.13 -6.03 - -0.16 -1295.1 -1644.86 -0.53 -0.36 -0.73 -0.16 -0.2

EBITDA per Share

-0.25 1.03 1.76 1.53 1.5 - 0.56 0.05 -0.29 - 0.64 -0.35 1.16 - 1.18 -0.01 0.28 - 1.41 1.58 1.75 - 1.59 1.33 1.27 - 1.42 1.22 0.98 - 1.21 0.98 0.9 - 0.92 0.87 0.96 - 0.84 -0.16 0.42 - 0.13 -3.15 - - - 0.04 -0.06 - -0.75 -0.83 -0.19

ROE %

-2.62 3.79 1.54 -3.53 -9.84 -13.81 -16.13 -15.69 -18.26 -9.63 -11.49 -8.94 -7.90 -11.52 -11.94 -10.33 -0.93 2.86 7.69 8.41 6.73 5.10 7.80 7.95 8.08 4.89 6.39 5.19 4.32 2.96 5.80 7.15 8.72 7.81 12.63 14.61 10.69 5.54 8.45 6.53 -2.97 -7.65 1.69 -0.34 10.77 -26.30 -16.24 -50.79 -90.31 -99.50 -33.67 -39.60 -45.62

ROA %

-0.28 1.78 0.87 -1.41 -4.13 -5.85 -6.80 -6.58 -7.53 -3.86 -4.65 -3.61 -3.35 -4.89 -5.16 -4.40 -0.28 1.33 3.56 3.88 3.08 2.34 3.48 3.46 3.46 2.08 2.86 2.51 2.20 1.55 3.15 3.96 4.87 4.38 6.94 7.90 5.75 2.94 5.61 5.73 -3.67 -7.04 -36.04 -41.46 -30.91 -57.97 -39.62 -57.29 -81.55 -82.73 -20.41 -24.01 -27.65

ROCE %

3.28 11.48 8.75 2.97 -4.20 -11.71 -13.58 -13.83 -17.80 -8.47 -8.30 -5.01 -2.68 -8.18 -10.55 -8.54 1.61 7.68 15.68 17.36 16.68 17.92 16.35 16.56 16.88 16.21 12.75 12.08 11.14 11.84 14.99 15.60 17.79 20.43 24.22 24.80 17.79 14.31 8.58 4.70 -2.76 -6.25 2.26 0.76 8.61 -16.98 -1.16 -36.10 -69.28 -88.16 -34.45 -34.55 -43.48

Current Ratio

1.5 2.1 2.0 2.0 1.8 1.8 1.8 1.8 1.9 1.9 1.7 1.7 1.8 1.7 1.7 1.7 1.7 1.9 1.9 1.9 1.9 1.9 1.9 1.9 1.9 1.7 1.7 1.7 1.7 2.1 2.1 2.1 2.1 2.3 2.3 2.3 2.3 2.2 2.1 2.1 2.1 12.6 - - 4.8 1.3 1.3 0.8 2.3 2.5 2.5 2.5 2.5

DSO

111.5 114.0 121.7 136.1 145.3 - 158.3 174.2 184.1 - 174.7 173.1 157.1 152.7 165.0 180.3 153.9 137.2 128.2 121.1 118.2 103.6 116.7 125.2 121.3 113.5 111.4 119.8 130.4 109.6 108.7 133.6 150.6 111.0 100.2 102.5 95.2 75.0 90.8 237.4 124.8 - 145.7 185.6 147.2 251.9 98.4 47.8 - - - - -

DIO

197.8 183.5 200.1 224.4 252.9 - 261.4 227.1 219.5 - 241.7 260.8 275.6 - 275.8 268.1 228.0 - 292.9 281.1 274.7 - 236.8 222.7 172.5 - 163.3 163.0 177.9 - 143.3 202.6 529.4 - 374.7 388.9 346.7 - 224.1 324.1 192.0 - 118.5 147.9 119.9 - 110.4 60.5 - - - - -

DPO

79.3 65.4 59.4 66.0 75.0 - 64.7 64.2 59.9 - 45.8 54.7 57.1 - 51.1 49.6 54.1 - 88.8 85.3 72.8 - 52.0 48.9 27.6 - 15.7 15.7 19.5 - 18.6 26.2 73.0 - 57.8 60.0 78.3 - 79.1 114.4 71.0 - 48.1 60.1 64.9 - 78.3 67.2 - - - - -

Operating Cycle

309.3 297.5 321.8 360.5 398.2 - 419.7 401.4 403.6 - 416.4 434.0 432.7 152.7 440.8 448.4 381.9 137.2 421.2 402.2 392.9 103.6 353.5 347.9 293.8 113.5 274.7 282.8 308.4 109.6 252.0 336.2 680.0 111.0 474.9 491.5 441.9 75.0 314.9 561.5 316.8 - 264.2 333.5 267.1 251.9 208.9 108.3 - - - - -

Cash Conversion Cycle

230.1 232.1 262.4 294.5 323.2 - 355.0 337.1 343.6 - 370.6 379.3 375.5 152.7 389.7 398.8 327.8 137.2 332.3 317.0 320.1 103.6 301.6 299.1 266.2 113.5 259.0 267.1 288.8 109.6 233.5 310.0 607.0 111.0 417.1 431.4 363.6 75.0 235.8 447.1 245.8 - 216.1 273.4 202.2 251.9 130.5 41.1 - - - - -

All numbers in USD currency